YJR146W Antibody

What is YJR146W and why are antibodies against it used in research?

YJR146W is an uncharacterized protein found in Saccharomyces cerevisiae (Baker's yeast) strain 204508/S288c. Despite being classified as a hypothetical protein, antibodies against YJR146W serve as valuable tools for studying this potential protein's expression, localization, and function in yeast cellular processes . These antibodies enable researchers to detect the presence of YJR146W in various experimental contexts, potentially contributing to our understanding of yeast proteome functionality. The antibody is particularly useful in fundamental yeast genetics research, where uncharacterized proteins represent significant knowledge gaps in our understanding of basic cellular processes.

What types of YJR146W antibodies are currently available for research?

The primary YJR146W antibody available for research is a rabbit polyclonal antibody specifically targeting the Saccharomyces cerevisiae YJR146W protein . This antibody is produced through antigen-affinity purification methods and belongs to the IgG isotype class. Polyclonal antibodies offer advantages for detecting novel proteins like YJR146W as they recognize multiple epitopes on the target antigen, potentially increasing detection sensitivity. Currently, monoclonal antibodies against YJR146W are not widely reported in research literature, likely due to the uncharacterized nature of the protein and the specialized research area.

What are the validated applications for YJR146W antibodies?

YJR146W antibodies have been validated for specific laboratory applications including:

• Western Blot (WB) - For detection and semi-quantitative analysis of YJR146W protein in yeast lysates

• Enzyme-Linked Immunosorbent Assay (ELISA) - For quantitative measurement of YJR146W in solution

How should appropriate controls be designed when using YJR146W antibodies?

When designing experiments with YJR146W antibodies, implementing rigorous controls is essential for reliable results. Based on recent antibody characterization standards, researchers should consider:

• Positive controls: Wild-type yeast expressing YJR146W

• Negative controls:

  • YJR146W knockout yeast strains (preferred method based on YCharOS findings)

  • Isotype control antibodies

  • Pre-immune serum controls

  • Secondary antibody-only controls

Recent research has demonstrated that knockout controls are superior to other negative control types, particularly for immunofluorescence imaging . For YJR146W studies, gene deletion strains available through yeast knockout collections represent the gold standard negative control. When these are unavailable, siRNA knockdown approaches may serve as alternative controls, though with lower confidence levels.

What is the recommended protocol for Western blot detection of YJR146W?

For optimal Western blot detection of YJR146W, the following methodological approach is recommended:

• Sample preparation:

  • Harvest yeast cells during logarithmic growth phase

  • Perform protein extraction using mechanical disruption (glass beads) in appropriate lysis buffer

  • Include protease inhibitors to prevent degradation

• Gel electrophoresis:

  • Load 20-50 μg of total protein per lane

  • Use 10-12% SDS-PAGE gels for optimal resolution

• Transfer and blocking:

  • Transfer to PVDF membrane (preferred over nitrocellulose for yeast proteins)

  • Block with 5% non-fat milk in TBST for 1 hour at room temperature

• Antibody incubation:

  • Dilute primary YJR146W antibody 1:1000 in blocking buffer

  • Incubate overnight at 4°C

  • Wash 3-5 times with TBST

  • Incubate with HRP-conjugated anti-rabbit secondary antibody (1:5000) for 1 hour

• Detection:

  • Develop using enhanced chemiluminescence (ECL) reagents

  • Include molecular weight markers to verify target band

The incorporation of both wild-type and YJR146W knockout samples as parallel controls is critical for proper interpretation, as recommended by antibody characterization consensus protocols .

What sample preparation methods maximize YJR146W detection sensitivity?

To maximize detection sensitivity for the hypothetical YJR146W protein:

• Optimize growth conditions: Test different growth phases and media compositions to identify conditions of highest YJR146W expression

• Enrichment strategies:

  • Subcellular fractionation to concentrate the protein if its localization is known

  • Immunoprecipitation to enrich the target protein before analysis

• Protein extraction methods:

  • Compare mechanical lysis (glass beads), enzymatic digestion (zymolyase), and chemical extraction

  • Evaluate different detergents (Triton X-100, NP-40, SDS) for optimal extraction

• Signal enhancement:

  • Consider using signal amplification systems (TSA, ABC method) for low-abundance proteins

  • Optimize antibody concentration through titration experiments

Researchers should document and report detailed methodologies to enhance reproducibility, addressing a significant challenge in antibody research where protocol variations contribute to irreproducibility .

How can YJR146W antibodies be validated for specificity in complex yeast protein mixtures?

Validating YJR146W antibody specificity requires a multi-faceted approach, especially given its uncharacterized nature:

• Knockout validation: The gold standard approach involves comparing antibody reactivity between wild-type and YJR146W knockout strains in Western blot and immunofluorescence applications

• Mass spectrometry confirmation:

  • Perform immunoprecipitation with the YJR146W antibody

  • Analyze precipitated proteins using mass spectrometry

  • Confirm presence of YJR146W peptides in precipitated material

• Epitope mapping:

  • Express recombinant fragments of YJR146W

  • Test antibody reactivity against these fragments

  • Identify specific binding regions

• Cross-reactivity assessment:

  • Test reactivity against closely related yeast proteins

  • Screen against other yeast species to evaluate species specificity

This comprehensive validation approach aligns with recent antibody characterization initiatives like YCharOS, which found that approximately 50-75% of proteins have at least one high-performing commercial antibody available .

What are the considerations for using YJR146W antibodies in co-immunoprecipitation experiments?

When designing co-immunoprecipitation experiments to identify YJR146W interaction partners:

• Buffer optimization:

  • Use mild detergents (0.1-0.5% NP-40, Triton X-100) to preserve protein-protein interactions

  • Include appropriate salt concentrations (100-150 mM NaCl) to reduce non-specific binding

  • Consider adding stabilizing agents like glycerol (10%) to preserve complex integrity

• Binding conditions:

  • Optimize antibody amount (typically 1-5 μg per reaction)

  • Determine optimal incubation time (2-16 hours) and temperature (4°C)

  • Evaluate various bead types (Protein A, Protein G, or conjugated magnetic beads)

• Controls for validation:

  • Include IgG isotype control reactions

  • Perform reciprocal co-IP using antibodies against suspected interaction partners

  • Use YJR146W knockout strains as negative controls

• Analysis considerations:

  • Confirm successful IP of YJR146W via Western blot before proceeding to interaction partner analysis

  • Consider mild elution conditions to preserve complexes for downstream analysis

  • Validate interactions using orthogonal methods (e.g., proximity ligation assay)

These methodological considerations address the challenges of working with an uncharacterized protein while maintaining scientific rigor.

How can computational antibody design approaches like RAbD be leveraged to develop improved YJR146W antibodies?

RosettaAntibodyDesign (RAbD) and similar computational approaches offer potential for developing enhanced YJR146W-specific antibodies:

• Structure prediction and epitope mapping:

  • Generate structural models of YJR146W using homology modeling

  • Identify optimal epitopes for antibody targeting based on:

    • Surface accessibility

    • Sequence uniqueness

    • Predicted structural stability

• In silico antibody design:

  • Utilize RAbD framework to sample diverse antibody sequences and structures

  • Employ Monte Carlo plus minimization (MCM) procedure to optimize binding interface

  • Incorporate CDR (Complementarity-Determining Region) cluster-based constraints

• Optimization strategies:

  • Focus design on complementarity-determining regions (CDRs)

  • Sample CDR backbones using flexible-backbone design protocol

  • Optimize either total Rosetta energy or interface energy based on specific research goals

• Experimental validation pipeline:

  • Express designed antibodies recombinantly

  • Test binding affinity using surface plasmon resonance or bio-layer interferometry

  • Validate specificity against YJR146W knockout controls

This computational approach has shown promise in developing antibodies with improved specificity and affinity, including successful cases with weak initial binders being enhanced to nanomolar affinity .

How should researchers address non-specific binding issues with YJR146W antibodies?

Non-specific binding is a common challenge when working with antibodies against uncharacterized proteins. To address this issue:

• Optimize blocking conditions:

  • Test different blocking agents (BSA, milk, casein, commercial blockers)

  • Increase blocking time or concentration if background persists

  • Consider adding 0.1-0.5% Tween-20 to reduce hydrophobic interactions

• Antibody dilution optimization:

  • Perform titration experiments to identify optimal antibody concentration

  • Consider using higher dilutions to reduce non-specific binding

  • Prepare antibody dilutions in fresh blocking buffer

• Pre-adsorption strategies:

  • Pre-incubate antibody with lysate from YJR146W knockout yeast

  • Remove complexes by centrifugation before using the antibody

• Stringency adjustments:

  • Increase salt concentration in wash buffers (150-500 mM NaCl)

  • Add low concentrations of SDS (0.01-0.05%) to wash buffers

  • Increase number and duration of wash steps

• Cross-reactivity identification:

  • Perform Western blot with 2D gel electrophoresis to identify cross-reactive proteins

  • Use mass spectrometry to identify non-specific targets

  • Modify experimental conditions based on known properties of cross-reactive proteins

These approaches should be systematically tested and documented to establish optimal conditions for specific detection.

What strategies can resolve contradictory results between different experimental methods using YJR146W antibodies?

When faced with contradictory results between different methods (e.g., Western blot vs. ELISA):

• Methodological analysis:

  • Examine how protein conformation differs between methods

  • Consider epitope accessibility in native vs. denatured conditions

  • Evaluate buffer compositions for compatibility with antibody binding

• Systematic validation approach:

  • Test antibody in multiple applications with appropriate controls

  • Document performance metrics for each application

  • Generate a comprehensive antibody performance profile

• Result reconciliation strategies:

  Method Combination	Potential Cause	Resolution Strategy
  WB positive, ELISA negative	Linear vs. conformational epitope	Use denatured protein in ELISA
  ELISA positive, WB negative	Protein aggregation in WB	Optimize sample preparation
  IF positive, WB negative	Low abundance in whole cell lysate	Enrich target protein compartment
  Multiple bands in WB	Degradation or isoforms	Perform mass spec identification

• Independent verification:

  • Use alternative detection methods (e.g., aptamers, nanobodies)

  • Generate additional antibodies against different epitopes

  • Apply genetic approaches (tagging, knockout) for validation

This systematic approach aligns with recommendations from antibody characterization initiatives that emphasize multi-method validation .

How can researchers distinguish between true YJR146W signal and artifacts in immunofluorescence applications?

For reliable immunofluorescence interpretation when studying YJR146W localization:

• Essential controls:

  • YJR146W knockout strain (negative control)

  • Secondary antibody-only control

  • Autofluorescence control (unstained sample)

  • Epitope-tagged YJR146W expressing strain (positive control)

• Signal validation techniques:

  • Co-localization with known subcellular markers

  • Correlation with expected biological patterns

  • Consistency across multiple fixation and permeabilization methods

  • Antibody concentration gradient testing

• Technical considerations:

  • Use multi-channel imaging to identify autofluorescence

  • Apply spectral unmixing for overlapping fluorophores

  • Implement deconvolution to improve signal-to-noise ratio

  • Consider super-resolution techniques for detailed localization

• Orthogonal validation:

  • Compare with live-cell imaging of fluorescently tagged YJR146W

  • Correlate with subcellular fractionation and biochemical detection

  • Validate with electron microscopy using immunogold labeling

Recent research has shown that knockout controls provide the most definitive validation for immunofluorescence applications, with superior performance compared to other control types .

How might new antibody characterization initiatives impact future YJR146W research?

Emerging antibody characterization initiatives will significantly influence YJR146W research:

• Standardized validation approach:

  • Implementation of consensus protocols developed by initiatives like YCharOS

  • Adoption of knockout-based validation as standard practice

  • Creation of centralized repositories for validated YJR146W antibody data

• Enhanced reproducibility:

  • Reduction in the estimated $0.4-1.8 billion annual losses due to poorly characterized antibodies

  • Increased confidence in published YJR146W research findings

  • Improved ability to build upon established results

• Resource development:

  • Generation of comprehensively characterized YJR146W antibody panels

  • Creation of reference materials for standardized testing

  • Development of recombinant antibodies with defined binding properties

• Methodological advancements:

  • Integration of machine learning approaches for antibody performance prediction

  • Application of high-throughput characterization technologies

  • Development of multiplexed validation platforms

These initiatives address the fundamental challenges in antibody research where approximately 50% of commercial antibodies fail to meet basic standards for characterization .

What novel applications might emerge for YJR146W antibodies in yeast functional genomics?

Future applications of YJR146W antibodies may include:

• Proteome-wide interaction mapping:

  • Integration with BioID or APEX proximity labeling methods

  • Application in large-scale co-immunoprecipitation studies

  • Development of antibody-based protein arrays for interaction screening

• Dynamic protein analysis:

  • Investigation of YJR146W expression across growth phases

  • Examination of post-translational modifications

  • Tracking protein turnover and degradation kinetics

• Advanced microscopy applications:

  • Implementation in super-resolution microscopy techniques

  • Application in live-cell antibody imaging (when membrane-permeable formats become available)

  • Integration with correlative light and electron microscopy

• Functional analysis tools:

  • Development of function-blocking YJR146W antibodies

  • Creation of conformation-specific antibodies to detect activation states

  • Application in targeted protein degradation approaches

These applications could help characterize this currently hypothetical protein and establish its role in yeast cellular processes.